Investors and Media

Revibe Technologies

At Revibe Technologies, we fuse technology with behavioral science to create solutions and improve lives. We are committed to helping kids struggling with attention deficits improve their focus and attention.

The time for digital therapy solutions is now.

  • Prescription drugs for ADHD have a large market and poor adherence, with a
    – $9.5 billion annual spend¹
    – <50% adherence rate²

  • There is a need and a demand for nondrug options for ADHD

  • With digital therapy, kids now have another option

REQUEST Investor Presentation

Watch What’s Coming!

Our future SaMD* will be designed to integrate with any smartwatch, revolutionizing treatment for one of the most prevalent childhood disorders, with the potential of improving focus at a rate approaching that of current pharmacologic standard-of-care treatments.

*Currently an investigational product. Not for sale.

SIGN UP FOR UPDATES

News and Media

Press Releases

Events

Join us at one of our events to learn more about our digital therapy.

Investor and Media Relations Contacts

Investor/Media Contact:
Joseph Koziak
Email: joe@revibetech.com
Cell: 480-254-8530